Specialty Generic Pharmaceuticals Market, By Types (Injectable, Oral Drugs and Others), By Indication (Oncology, Inflammatory conditions, Multiple sclerosis, and Hepatitis C), By End Use, and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025
102 Pages | Published Date : 13 / 09 / 17 | Report Code: AV101 | Report Format: PDF
The specialty generic pharmaceuticals market is estimated to represent a global market of USD 28.7 billion by 2016 with growth rate of 20.8%.
Spending on specialty generic pharmaceuticals market is growing rapidly over past few years owing to the growing demand for cost effective therapeutics for various disease indications. It is analyzed that the rise in cost of specialty therapeutic treatments were the primary driver for the growth in spending compared to the increased utilization of specialty generics. The costs for specialty therapeutics are often high compared to other treatment options. However, these drugs are exhibit life-changing potential and offer high effectiveness in treatment of life threatening chronic conditions. Factors such as rising number of off-patent specialty drugs, increasing demand for generic specialty drugs due to low cost.
Drug spending on specialty generics is also expected to rise owing to the rise in prevalence of chronic diseases such as inflammatory conditions, multiple sclerosis, oncology and others drives the market growth. According to the Health of America, spending will increase at a higher growth rate for specialty pharmaceuticals. This spending is expected to cover by health insurance under the pharmacy benefits rather than medical benefits. However, advent of biologic therapeutics i.e. biosimilar is expected to cut cost of many commercially available generic therapeutics. Biosimilars are less costly and used treat a range of diseases including rheumatoid arthritis, cancer, diabetes and others.
The global specialty generic pharmaceutic market is categorized in terms of injectables, oral drugs and others. Among which, oral and self-injectable specialty therapeutics has been increasing owing to the technological advancements. Injectable generic therapeutics is considered to be the fast catching market segment, growing constantly over the forecast period. Injectable generics for oncology treatment is widely in demand across the globe. Therapeutics such as Avastin(Bevacizumab), Taxol(Pacitaxel), Doxil(Doxorubicin), Paraplatin(Carboplatin), Sutent(Sunitinib), Votrient(Pazopanib) and others are some of the injectable oncology therapeutics.
Based on indication, the market is divided as Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, and Others. Of which, we noticed that the growth of specialty genetics spending for hepatitis indication is increasing very rapidly over the forecast year. Growth of this segment is majorly attributed to the high demand coupled with increasing incidence of this disease. Introduction of novel generic therapeutics is also considered to be the primary for this market growth. End use segment is covered under Specialty pharmacies, Retail pharmacies and Hospital pharmacies. Specialty pharmacies accounted for the largest share of the global market, captured around USD 21.6 billion in 2016 and is expected to dominate the market over the forecast period.
Key Vendor Takeaway
Key companies that spend on the specialty generic drugs have increased at significant rate compared to the traditional pharmaceuticals. As per the estimates, around USD 87 billion was spent on specialty therapeutics by 2012 and the spending could reach to around USD 350 billion by 2020 (around increase by 26%). Companies such as Teva Generics, Mylan N.V., Pfizer, Inc. and Novartis AG are on forefront of specialty generic pharmaceuticals market. These companies are engaged in extensive research and development activities to develop novel generic therapeutics to enhance their market share.
Pfizer, Inc. captured significant share of the market in 2016. The company has adopted advanced technologies and formularies for development of high quality generics. Moreover, the company is highly inclined toward maintaining competition in the market as well as delivering economic value to customers and satiate unmet demands. One of the major deals of Pfizer, Inc. was the acquisition of Hospira, Inc. in 2015, which resulted in capturing of greater share of the generic injectables market space.
The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.
The years considered for the study are:
- Historical Year – 2014 & 2015
- Base Year – 2015
- Estimated Year – 2016
- Projected Year – 2025
- Traders, Distributors, And Suppliers
- Government and Regional Agencies and Research Organizations
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY TYPES
MARKET, BY INDICATION
- Multiple sclerosis
- Hepatitis C
MARKET, BY END USE
- Specialty Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
MARKET, BY REGION
- North America
- Asia Pacific
- Rest of the World
MARKET, BY COUNTRY
- Further Breakdown of The North America Market
- Further Breakdown of The Europe Market
- Rest of Europe
- Further Breakdown of The APAC Market
- Rest of APAC
- Further Breakdown of The Rest of the World Market
- Middle East and Africa
- Latin America
1. SPECIALTY GENERIC PHARMACEUTICALS MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. SPECIALTY GENERIC PHARMACEUTICALS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. SPECIALTY GENERIC PHARMACEUTICALS INDUSTRY STUDY
4.1. Company Activity Analysis
4.2. Regulatory Framework Analysis
4.3. Pipeline Analysis
4.4. Value Chain Analysis
5. SPECIALTY GENERIC PHARMACEUTICALS MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
6. SPECIALTY GENERIC PHARMACEUTICALS MARKET – BY TYPES:
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. SPECIALTY GENERIC PHARMACEUTICALS MARKET – BY INDICATION:
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. Inflammatory conditions
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Multiple sclerosis
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5. Hepatitis C
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. SPECIALTY GENERIC PHARMACEUTICALS MARKET – BY END USE:
8.2. Specialty pharmacies
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Retail pharmacies
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4. Hospital pharmacies
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. SPECIALTY GENERIC PHARMACEUTICALS MARKET– BY GEOGRAPHY
9.2. North America
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
220.127.116.11. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
18.104.22.168. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
22.214.171.124. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
126.96.36.199. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3.5. Rest of Europe
188.8.131.52. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4. Asia Pacific (APAC)
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
184.108.40.206. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
220.127.116.11. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4.5. Rest of APAC
18.104.22.168. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5. Rest of the World
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5.3. Latin America
22.214.171.124. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5.4. Middle East and Africa
126.96.36.199. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10. KEY VENDOR ANALYSIS
10.1. Teva Pharmaceuticals, Inc.
10.1.1. Company Overview
10.1.2. SWOT Analysis
10.1.3. Key Developments
10.2. Valeant Pharmaceuticals
10.2.1. Company Overview
10.2.2. SWOT Analysis
10.2.3. Key Developments
10.3. Sun Pharmaceuticals
10.3.1. Company Overview
10.3.2. SWOT Analysis
10.3.3. Key Developments
10.4. Mylan N.V.
10.4.1. Company Overview
10.4.2. SWOT Analysis
10.4.3. Key Developments
10.5. Pfizer, Inc.
10.5.1. Company Overview
10.5.2. SWOT Analysis
10.5.3. Key Developments
10.6. Novartis AG
10.6.1. Company Overview
10.6.2. SWOT Analysis
10.6.3. Key Developments
11. 360 DEGREE ANALYSTVIEW
12.1. Research Methodology
12.4. Contact Us
SCOPE AND OBJECTIVES :
The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the market by its major segments, which include the source, disease end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT :
• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow
AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:
- Official Company’s Website, Financial and Annual Reporting
- Government Statistical Data
- Online Publishing Articles
- Industry Player’s Investor Presentations
- Economic News Articles
- National and International Trade Associations
- The Financial, Business and Mainstream Press
- Industry Study Groups and Other Semi-Official Sources
- Many Other Informative Channels Related to the Market Topics
Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide
In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.
Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.
Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.
We strive to become one of the trusted partner of our client by offering value added services and concrete research data.
From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.
Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.
Data Accuracy and Reliability
We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.
We offer most competitive pricing policy across the research industry
Why Choose Us
We devise research report with quality data:
Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.
We work with businesses just like yours:
AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.